Related Experiment Videos
Relationship between skin type and erythemal response to anthralin
The British Journal of Dermatology
|September 1, 1983
Summary
Anthralin erythema dose-response curves were analyzed in psoriasis patients. While a minor difference was found between skin types, it did not fully explain increased irritancy in fair skin.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Chronic plaque psoriasis is a common skin condition.
- Anthralin is a topical treatment for psoriasis.
- Patient skin type may influence treatment response and side effects.
Purpose of the Study:
- To investigate the dose-response relationship of anthralin-induced erythema across different skin types.
- To determine if skin type explains the clinical observation of increased anthralin irritancy in fair-skinned individuals.
Main Methods:
- Dose-response curves for anthralin-induced erythema were generated.
- Thirty adult patients with chronic plaque psoriasis and varying skin types were included.
- Statistical analysis compared erythema responses between different skin types.
Main Results:
- A small, statistically significant difference in anthralin erythema dose-response curves was observed between skin types I and IV.
- This observed difference was not considered substantial enough to fully account for the clinical perception of greater anthralin irritancy in fair skin.
Conclusions:
- The study provides quantitative data on anthralin's dose-response in psoriasis patients.
- Skin type has a minor effect on anthralin-induced erythema, but other factors likely contribute to perceived irritancy differences.